e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nitric oxide in the COPD pathogenesis in patients with pulmonary tuberculosis
L. Kiryukhina (Saint-Petersburg, Russian Federation), M. Dyakova (Saint-Petersburg, Russian Federation), D. Esmedlyaeva (Saint-Petersburg, Russian Federation)
Source:
International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Session:
Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Session type:
Thematic Poster
Number:
4104
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Kiryukhina (Saint-Petersburg, Russian Federation), M. Dyakova (Saint-Petersburg, Russian Federation), D. Esmedlyaeva (Saint-Petersburg, Russian Federation). Nitric oxide in the COPD pathogenesis in patients with pulmonary tuberculosis. 4104
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Nitric oxide in acute testing in patients with pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 277s
Year: 2004
Fractional exhaled nitric oxide in chronic obstructive pulmonary disease
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Exhaled nitric oxide levels in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD)
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013
Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Exhaled nitric oxide measurement in the diagnosis and management of pulmonary tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Inhaled nitric oxide in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Eur Respir J 2006; 28: Suppl. 50, 399s
Year: 2006
Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Nitric oxide vs prostacyclin in chronic high-flow pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 24s
Year: 2002
Exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Airway and systemic nitric oxide pathway in COPD
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Exhaled nitric oxide and hydrogen peroxide in patients with asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 617s
Year: 2007
Nitric oxide attenuates the Th1 cells that are upregulated in patients with active pulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 466s
Year: 2001
Exhaled nitric oxide and pulmonary function in children with sickle cell disease
Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management
Year: 2010
Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide
Source: Eur Respir J 2007; 30: 26-30
Year: 2007
Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2016; 48: 1386-1395
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept